市場調査レポート

商品コード

1593445

臨床試験イメージング市場規模、シェア、成長分析、サービス・ソフトウェア別、モダリティ別、治療領域別、エンドユーザー別、地域別 - 産業予測、2024年～2031年

Clinical Trial Imaging Market Size, Share, Growth Analysis, By Service and Software, By Modality, By Therapeutic Area, By End User, By Region - Industry Forecast 2024-2031

出版日: 2024年11月14日
発行: SkyQuest
ページ情報: 英文 194 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 763,518円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 893,172円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,022,826円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.06円

全表示
概要
目次

概要

サンプル依頼リストに入れる

臨床試験イメージングの世界市場規模は、2022年に12億2,000万米ドルと評価され、2023年の13億2,000万米ドルから2031年には24億2,000万米ドルに成長し、予測期間（2024-2031年）のCAGRは7.82％で成長する見通しです。

バイオテクノロジーと製薬セクターは、さまざまな疾患に対する新薬の創出を目的とした研究開発への投資の急増を主な要因として、力強い成長を遂げようとしています。この成長は、医療機器製造の強化や臨床検査の改善を目的とした先進イメージング技術の統合を目指す、医療イメージング領域における注目すべきM&A動向によって補完されています。医療画像業界はダイナミックであるにもかかわらず、医療画像企業への大幅な資本配分に後押しされ、安定した勢いを見せています。技術の進歩は、臨床試験イメージングデータの収集、分析、表示に革命をもたらしました。特に、画像解析ソフトウェアは臨床研究において極めて重要なツールとして台頭し、データ管理方法の強化を通じて一貫性、正確性、拡張性、規制遵守などのメリットを提供しています。さらに、コンピュータ技術への依存度が高まり、計算能力が強化されたことで、臨床試験における画像処理能力がさらに向上すると期待されています。Quantitative Imaging Biomarker Alliance（QIBA）プロトコルの確立により、データ収集のための標準化された手法が導入され、臨床試験で採用される手法から現実的で比較可能なデータが確実に得られるようになった。その結果、イメージング技術は進化を続け、バイオテクノロジー業界と製薬業界は、現在進行中の医療課題に直面しながらも、持続的な成長と革新を遂げることができるようになった。

市場概要
北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域

競合情勢

上位5社の比較
主要企業の市場ポジショニング（2023年）
主な市場企業が採用した戦略
市場における最近の活動
主要企業の市場シェア（2023年）

主要企業プロファイル

ICON plc
Medpace
Clario
IXICO plc
Resonance Health Ltd.
Radiant Sage
WCG Clinical
Medical Metrics, Inc.
Prism Clinical Imaging
Boston Imaging Core Lab
Voiant
Calyx
Biospective Inc.
Micron, Inc.
Imaging Endpoints
Perspectum
Competence Network Life Sciences（Pharmtrace）
Median Technologies
Image Core Lab
Image Analysis Group（IAG）

Product Code: SQMIG35H2309

Global Clinical Trial Imaging Market size was valued at USD 1.22 billion in 2022 and is poised to grow from USD 1.32 billion in 2023 to USD 2.42 billion by 2031, growing at a CAGR of 7.82% during the forecast period (2024-2031).

The biotechnology and pharmaceutical sectors are poised for robust growth, primarily driven by escalating investments in research and development aimed at creating new drugs for a variety of diseases. This growth is complemented by a noteworthy trend of mergers and acquisitions within the medical imaging domain, which seek to integrate advanced imaging technologies to enhance the manufacturing of medical devices and improve clinical investigations. Despite the dynamic nature of the medical imaging landscape, these industries are seeing steady momentum, propelled by significant capital allocation toward medical imaging firms. Technological advancements have revolutionized the collection, analysis, and presentation of clinical trial imaging data. Notably, image analysis software has emerged as a pivotal tool in clinical research, offering benefits such as increased consistency, accuracy, scalability, and regulatory compliance through enhanced data management methods. Additionally, the growing reliance on computer technology and augmented computing power is expected to further enrich imaging capabilities in clinical trials. The establishment of the Quantitative Imaging Biomarker Alliance (QIBA) protocol has introduced standardized techniques for data collection, ensuring that methodologies employed in clinical trials yield realistic and comparable data. As a result, imaging techniques continue to evolve, positioning the biotechnology and pharmaceutical industries for sustained growth and innovation in the face of ongoing medical challenges.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Clinical Trial Imaging market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Clinical Trial Imaging Market Segmental Analysis

Global Clinical Trial Imaging Market is segmented by Service and Software, Modality, Therapeutic Area, End User, and Region. Based on Service and Software, the market is segmented into Services (Operational Imaging Services, Read Analysis Services, System And Technical Support Services, Trial Design And Consulting Services), Software. Based on Modality, the market is segmented into Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Positron Emission Tomography, X-Ray, Others. Based on Therapeutic Area, the market is segmented into Oncology, Infectious Diseases, Neurology, Cardiovascular System Disorders, Endocrinology, Immunological Disorders, Others. Based on End User, the market is segmented into Pharmaceutical & Biotechnology Companies, Medical Device Manufacturers, Contract Research Organizations, Academic And Government Research Institutes, Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Clinical Trial Imaging Market

The Global Clinical Trial Imaging market is significantly propelled by rising investments in research and development (R&D) activities within the pharmaceutical and biotechnology sectors. As the complexity of drug development escalates, the demand for precise imaging technologies becomes paramount to effectively monitor treatment outcomes and disease progression during clinical trials. Advanced imaging modalities such as MRI, PET, and CT scans provide essential data that enhances the understanding of a therapy's safety and efficacy, which is critical for regulatory approvals. This growing reliance on sophisticated imaging techniques not only supports the validation of new treatments but also drives innovation and competitiveness in the market.

Restraints in the Global Clinical Trial Imaging Market

The Global Clinical Trial Imaging market faces a significant restraint due to the high costs associated with advanced imaging technologies, such as MRI, PET, and CT scans. These elevated prices can substantially inflate the overall expenses of clinical trials, posing a particular challenge for smaller pharmaceutical companies and research institutions that may lack the financial resources to incorporate these sophisticated imaging modalities. Furthermore, the need for specialized technicians and radiologists further exacerbates the financial burden, often leading to a preference for more conventional imaging methods. This financial strain limits the capacity of many organizations to leverage advanced imaging, potentially stunting innovation and slowing down the progress of clinical research.

Market Trends of the Global Clinical Trial Imaging Market

The Global Clinical Trial Imaging market is experiencing a significant trend towards integrating Artificial Intelligence (AI) and machine learning technologies into imaging systems. This innovation enhances the precision and efficiency of image analysis, significantly minimizing human error and accelerating result turnaround times. AI-driven tools are automating complex imaging processes, which not only streamlines the clinical diagnostic workflow but also makes advanced imaging techniques more accessible and cost-effective. As healthcare stakeholders increasingly recognize the benefits of AI in improving clinical trial outcomes, the demand for these cutting-edge imaging solutions is poised for continued growth, shaping the future of clinical research.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Ecosystem of the Market
Patent Analysis
Pricing Analysis
Trade Analysis
Value Chain Analysis
Supply Chain Analysis
Customer & Buying Criteria Analysis
Case Study Analysis
Regulatory Landscape
Innovation Matrix
Top Investment Analysis
Key Success Factor
Degree of Competition

Clinical Trial Imaging Market by Service and Software

Market Overview
Services
- Operational Imaging Services
- Read Analysis Services
- System & Technical Support Services
- Trial Design & Consulting Services
Software

Clinical Trial Imaging Market by Modality

Market Overview
Computed Tomography
Magnetic Resonance Imaging
Ultrasound
Positron Emission Tomography
X-Ray
Others

Clinical Trial Imaging Market by Therapeutic Area

Market Overview
Oncology
Infectious Diseases
Neurology
Cardiovascular System Disorders
Endocrinology
Immunological Disorders
Others

Clinical Trial Imaging Market by End User

Market Overview
Pharmaceutical & Biotechnology Companies
Medical Device Manufacturers
Contract Research Organizations
Academic And Government Research Institutes
Others

Clinical Trial Imaging Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

ICON plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medpace
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Clario
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
IXICO plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Resonance Health Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Radiant Sage
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
WCG Clinical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medical Metrics, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Prism Clinical Imaging
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Imaging Core Lab
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Voiant
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Calyx
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biospective Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Micron, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Imaging Endpoints
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Perspectum
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Competence Network Life Sciences (Pharmtrace)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Median Technologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Image Core Lab
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Image Analysis Group (IAG)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

臨床試験イメージング市場規模、シェア、成長分析、サービス・ソフトウェア別、モダリティ別、治療領域別、エンドユーザー別、地域別 - 産業予測、2024年～2031年

Clinical Trial Imaging Market Size, Share, Growth Analysis, By Service and Software, By Modality, By Therapeutic Area, By End User, By Region - Industry Forecast 2024-2031

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

臨床試験イメージング市場：サービスとソフトウェア別

臨床試験イメージング市場：モダリティ別

臨床試験イメージング市場：治療領域別

臨床試験イメージング市場：エンドユーザー別

臨床試験イメージング市場：地域別